Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Revenue by Segment

Financials in millions SGD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Medical Diagnostics and Treatments	12.52M	12.55M	14.67M	15.43M	13.49M
Radiation Therapy and Medical Oncology Services	3.19M	3.16M	1.97M	800.88K	321.13K
Total	15.72M	15.71M	16.65M	16.23M	13.81M

Revenue by Geography

Financials in millions SGD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Singapore	15.72M	15.71M	16.65M	16.23M	13.81M
Total	15.72M	15.71M	16.65M	16.23M	13.81M

Data Source: S&P Global Market Intelligence Last updated: Aug 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error